{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:00:16Z","timestamp":1793642416219,"version":"4.5.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T00:00:00Z","timestamp":1665100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pediatr-neonatol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatrics &amp; Neonatology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.pedneo.2022.05.018","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T01:36:48Z","timestamp":1666143408000},"page":"176-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Reappraisal of therapeutic vancomycin trough concentrations with empirical dosing in neonatal infections"],"prefix":"10.1016","volume":"64","author":[{"given":"Tzung-Yi","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Li","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1087-6965","authenticated-orcid":false,"given":"Chung-Min","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Lan","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0609-3311","authenticated-orcid":false,"given":"Wu-Shiun","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedneo.2022.05.018_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1542\/peds.110.2.285","article-title":"Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network","volume":"110","author":"Stoll","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedneo.2022.05.018_bib2","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1348-0421.2007.tb03968.x","article-title":"Methicillin resistance in Staphylococcus aureus and coagulase-negative staphylococci: epidemiological and molecular aspects","volume":"51","author":"Martins","year":"2007","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.pedneo.2022.05.018_bib3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1684-1182(10)60064-3","article-title":"Long-term characteristics of healthcare-associated infections in a neonatal intensive care unit","volume":"43","author":"Ho","year":"2010","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.pedneo.2022.05.018_bib4","doi-asserted-by":"crossref","first-page":"F327","DOI":"10.1136\/archdischild-2018-315412","article-title":"Challenges and opportunities for antibiotic stewardship among preterm infants","volume":"104","author":"Mukhopadhyay","year":"2019","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.pedneo.2022.05.018_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2165\/00003088-199733010-00004","article-title":"Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children","volume":"33","author":"Rodvold","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pedneo.2022.05.018_bib6","series-title":"British national formulary for children 2014\u20132015","first-page":"289","year":"2014"},{"key":"10.1016\/j.pedneo.2022.05.018_bib7","series-title":"Neofax\u00ae","first-page":"102","author":"Young","year":"2011"},{"key":"10.1016\/j.pedneo.2022.05.018_bib8","doi-asserted-by":"crossref","first-page":"F278","DOI":"10.1136\/archdischild-2014-307725","article-title":"Neonatal vancomycin trough level audit using British National Formulary for Children dosing","volume":"100","author":"Petrie","year":"2015","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.pedneo.2022.05.018_bib9","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/INF.0000000000000664","article-title":"Achievement of therapeutic vancomycin trough serum concentrations with empiric dosing in neonatal intensive care unit patients","volume":"34","author":"Ringenberg","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.pedneo.2022.05.018_bib10","series-title":"Nelson's textbook of pediatrics","first-page":"1414","article-title":"Principles of antibacterial therapy","author":"Schleiss","year":"2020"},{"key":"10.1016\/j.pedneo.2022.05.018_bib11","series-title":"Practical neonatology medical manual","first-page":"434","year":"2014"},{"key":"10.1016\/j.pedneo.2022.05.018_bib12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.pedneo.2022.05.018_bib13","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.pedneo.2022.05.018_bib14","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1128\/AAC.03620-14","article-title":"Association between vancomycin trough concentrations and area under the concentration-time curve in neonates","volume":"58","author":"Frymoyer","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pedneo.2022.05.018_bib15","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1177\/009127000104100901","article-title":"The influences of renal function and maturation on vancomycin elimination in newborns and infants","volume":"41","author":"Capparelli","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pedneo.2022.05.018_bib16","first-page":"83","article-title":"Optimization of vancomycin dosing in very low-birth-weight preterm neonates","volume":"32","author":"Madigan","year":"2015","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.pedneo.2022.05.018_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/pch\/19.6.291","article-title":"Assessment of initial vancomycin dosing in neonates","volume":"19","author":"Dersch-Mills","year":"2014","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.pedneo.2022.05.018_bib18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12098-008-0055-0","article-title":"Fluid and electrolyte management in term and preterm neonates","volume":"75","author":"Chawla","year":"2008","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.pedneo.2022.05.018_bib19","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental pharmacology-drug disposition, action, and therapy in infants and children","volume":"349","author":"Kearns","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pedneo.2022.05.018_bib20","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1203\/00006450-199411000-00005","article-title":"Renal function in preterm neonates","volume":"36","author":"Bueva","year":"1994","journal-title":"Pediatr Res"},{"key":"10.1016\/j.pedneo.2022.05.018_bib21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/AAC.31.1.52","article-title":"Vancomycin pharmacokinetics and dose recommendations for preterm infants","volume":"31","author":"James","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pedneo.2022.05.018_bib22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/adc.58.3.212","article-title":"References ranges for plasma creatinine during the first month of life","volume":"58","author":"Rudd","year":"1983","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.pedneo.2022.05.018_bib23","doi-asserted-by":"crossref","first-page":"F290","DOI":"10.1136\/adc.2009.197699","article-title":"Perinatal drug exposure and renal function in very preterm infants","volume":"96","author":"Vieux","year":"2011","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.pedneo.2022.05.018_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106300","article-title":"Determination of vancomycin exposure target and individualised dosing recommendations for neonates: model-informed precision dosing","volume":"57","author":"Tang","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.pedneo.2022.05.018_bib25","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s10096-018-3277-8","article-title":"Factors impacting unbound vancomycin concentrations in neonates and young infants","volume":"37","author":"Smits","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.pedneo.2022.05.018_bib26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/INF.0000000000000573","article-title":"No survival benefit with empirical vancomycin therapy for coagulase-negative staphylococcal bloodstream infections in infants","volume":"34","author":"Ericson","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.pedneo.2022.05.018_bib27","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/INF.0000000000000850","article-title":"Survival benefit of empirical therapy for Staphylococcus aureus bloodstream infections in infants","volume":"34","author":"Thaden","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.pedneo.2022.05.018_bib28","first-page":"476","article-title":"Challenges of vancomycin dosing and therapeutic monitoring in neonates","volume":"25","author":"Pham","year":"2020","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.pedneo.2022.05.018_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jpids\/pix109","article-title":"Individualized empiric vancomycin dosing in neonates using a model-based approach","volume":"8","author":"Frymoyer","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.pedneo.2022.05.018_bib30","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/cid\/cir529","article-title":"Vancomycin therapeutic guidelines: closer examination of neonatal pharmacokinetics","volume":"53","author":"Croes","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pedneo.2022.05.018_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01647-17","article-title":"Evaluating the relationship between vancomycin trough concentration and 24-hour area under the concentration-time curve in neonates","volume":"62","author":"Tseng","year":"2018","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Pediatrics &amp; Neonatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957222002145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957222002145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:57:14Z","timestamp":1761749834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875957222002145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1875957222002145"],"URL":"https:\/\/doi.org\/10.1016\/j.pedneo.2022.05.018","relation":{},"ISSN":["1875-9572"],"issn-type":[{"value":"1875-9572","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reappraisal of therapeutic vancomycin trough concentrations with empirical dosing in neonatal infections","name":"articletitle","label":"Article Title"},{"value":"Pediatrics & Neonatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedneo.2022.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Taiwan Pediatric Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}